Cannabinoid API Solutions is a distribution company dedicated to the global marketing, sales and distribution of pharmaceutical grade hemp-based Cannabinoid Active Pharmaceutical Ingredients.
Our exclusive partner, XXII Century, offers a full line of isolate form pharmaceutical grade Cannabinoid Active Pharmaceutical Ingredients including Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC) and other minor cannabinoids. These APIs are manufactured by their subsidiary company, GVB Biopharma, located in Oregon.
22nd Century uses modern plant breeding technologies by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields. GVB Biopharma’s vertically integrated cannabinoid production utilizes their innovative technology and IP that results in high quality, affordable, commercially viable products. This combination with their projected 2023 expansion will enable 22nd Century to become the largest supplier of hemp-based Cannabinoid APIs globally.
Cannabinoid API Solutions will utilize the resources of Transo-Pharm USA and GmbH to provide global support to pharmaceutical companies engaging in clinical and pre-clinical activities with CBD, CBG, and other minor cannabinoid APIs.
We can offer companies the unique solution of starting their clinical trial activities with our API and provide commercial scale quantities to support their post approval launch requirements.
